Stability of extemporaneously prepared oxandrolone oral suspensions

American Journal of Health-System Pharmacy

Volumn 68, Issue 6, 2011, Pages 519-521

  Johnson, Cary E ^a,b   Cober, Mary Petrea ^c,d   Hawkins, Katherine A ^e   Julian, Justin D ^f  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^c AKRON CHILDREN'S HOSPITAL   (United States)

^d NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^e is an assistant professor of nursing at Bethel College   (United States)

^f THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Androgens; Color; Compounding; Concentration; Hydrogen ion concentration; Oxandrolone; Stability; Storage; Suspensions; Taste; Vehicles

Indexed keywords

OXANDROLONE;

ARTICLE; DRUG BIOAVAILABILITY; DRUG STABILITY; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PLASTIC BOTTLE; PRIORITY JOURNAL; ROOM TEMPERATURE; SUSPENSION; TABLET FORMULATION;

EID: 79956044148     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100225     Document Type: Article

References (4)

1. Orr R, Singh MF. The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety. Drugs. 2004; 64:725-50. (Pubitemid 38471373)
2. Oxandrin (oxandrolone tablets, USP) package insert. East Brunswick, NJ: Savient Pharmaceuticals; 2005 May.
3. Oxandrolone. The United States pharmacopeia, 32nd revision, and The national formulary, 27th ed. Rockville, MD: United States Pharmacopeial Convention; 2009:3149-52.
4. Leinonen A, Kuuranne T, Kotiaho I et al. Screening of free 17-alkyl-substituted anabolic steroids in human urine by liquid chromatography-electrospray ionization tandem mass spectrometry. Steroids. 2004; 69:101-9. (Pubitemid 38315083)